Xsphera Biosciences Inc’s Post

Cell Therapies have the potential to revolutionize the oncology industry, but can they make it through development and into the clinic? At Xsphera Biosciences Inc. I work on helping clients get their cell therapies like CAR-T cells to clinical success. From developing a platform to track labelled cells migration patterns, to then quantifying the cytotoxicity in our tumor microenvironment platform, XspheraCT is a great resource for companies developing cell therapies. Please check out our newly released white paper, documenting the extent of our advanced approach to translational research. #oncology #TME #PDOTS #organoids #celltherapy #cancer #immunoncology #solidtumor

Calidi Biotherapeutics (NYSE AMERICAN: CLDI) is up over 50% in trading today! Calidi Biotherapeutics is presenting three abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: May 31, 2024 - June 4, 2024 in a poster session. These presentations will include: City of Hope-led Phase 1 study update of CLD-101: This study focuses on treating recurrent high-grade glioma and is advancing into its fourth participant cohort. CLD-101, part of the NeuroNova program, utilizes tumor-tropic neural stem cells (NSCs) to deliver an oncolytic adenovirus (CRAd-S-pk7) specifically to tumor sites. Sign up for alerts to stay ahead on $CLDI: https://ow.ly/W5Np50S2efX #cancer #oncolyticviruses #immune #immunesystem #tumors #cells #tech #technology #iv #oncology #stocks #investing #nyse

How can we unlock the next level of precision in cancer research and patient care? The answer lies in the power of liquid biopsies, especially through the strategic collection of longitudinal plasma samples. This innovative approach is setting new benchmarks in understanding and treating cancer, with the ultimate goal of significantly improving patient outcomes. Take a quick look at this latest white paper to gain insights 👇 :

Reviewing the role of pancreatic cancer exosomes: in this article, Weibin Wang at Chinese Academy of Medical Sciences and collaborators examined current knowledge on how exosomes mediate distant cell-cell communication in pancreatic cancer and discussed their potential clinical applications and future research directions https://lnkd.in/eb6XuGCJ They suggested that combining these biomarkers in a multi-omics approach could significantly enhance the sensitivity and specificity of liquid biopsies. An article co-authored by Cheng Qin, Tianyu Li, Chen Lin, Bangbo Zhao, Zeru Li and Yutong Zhao #extracellularvesicles #exosomes #tumormicroenvironment #liquidbiopsy #pancreaticcancer #Vesiculab

In case you missed it: How spatial transcriptomics can enhance your understanding of cancer biology and therapeutic response

In our new white paper, we look at how liquid biopsies can be used to precisely monitor how well tumors respond to treatment before changes can be seen on imaging tests. Our unique high-quality cell-free plasma biobank is exclusively focused on collecting liquid biopsy samples from cancer patients. ✅Gain insights into our liquid biopsy collection process ✅Understand the advantages and benefits of utilizing longitudinal plasma samples for cancer research ✅Explore applications of longitudinal plasma samples for biomarker research and development of companion diagnostics Download our white paper now ➡️ https://bit.ly/3uJImZe #PrecisionMedicine #Oncology #LiquidBiopsies #CancerResearch #Biobank #Biomarkers

Remarkable progress in cancer research and treatment has paved the way for the development of more targeted therapeutic approaches. These breakthroughs have expanded cancer treatment options available to patients and are leading the way toward precision oncology. Download our latest white paper to understand: ➡️The transformative potential of liquid biopsies, including longitudinal plasma sample collection, in advancing cancer research with the goal of improving patient outcomes ➡️The initiatives taken to establish a vast longitudinal cell-free plasma biobank by providing researchers with highly comprehensive datasets that are a rich source of data for investigating tumor evolution, tumor heterogeneity, discovering predictive biomarkers, and tracking treatment response and resistance Download now ➡️ https://bit.ly/3OlugEH #Oncology #LiquidBiopsy #Biomarker #CancerResearch #Biotech #Bioscience

SOTIO’s research team and scientists at Weill Cornell Medicine (Medical college) recently published a new review of the role of type I interferon (IFN) in #cancer biology & treatment. The article covers the fundamental aspects of type I IFN signaling and their context-dependent impact on malignant transformation, tumor progression, response to cancer immunotherapy and targeted therapies, such as antibody drug conjugates. Read more in Immunological Reviews: https://bit.ly/46YsxMB   #biotechnology #oncology #research #jsmePPF

Breakthroughs in cancer treatment options are leading the way toward precision oncology. Download this white paper to discover the potential of liquid biopsies, including longitudinal plasma sample collection, in advancing cancer research to improve patient outcomes You can further understand the initiatives taken to establish a vast longitudinal cell-free plasma biobank by providing researchers with highly comprehensive datasets that are a rich source of data for investigating tumor evolution, tumor heterogeneity, discovering predictive biomarkers, and tracking treatment response and resistance. #PrecisionMedicine #Oncology #LiquidBiopsies #CancerResearch #Biobank #Biomarkers

Breakthroughs in cancer treatment options are leading the way toward precision oncology. Download this white paper to discover the potential of liquid biopsies, including longitudinal plasma sample collection, in advancing cancer research to improve patient outcomes You can further understand the initiatives taken to establish a vast longitudinal cell-free plasma biobank by providing researchers with highly comprehensive datasets that are a rich source of data for investigating tumor evolution, tumor heterogeneity, discovering predictive biomarkers, and tracking treatment response and resistance. #PrecisionMedicine #Oncology #LiquidBiopsies #CancerResearch #Biobank #Biomarkers